What is clinically meaningful: Outcome measures in pain clinical trials

被引:103
|
作者
Farrar, JT [1 ]
机构
[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
关键词
clinical trials; pain measurement; randomized controlled trials; reproducibility of results; treatment outcome;
D O I
10.1097/00002508-200006001-00018
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The goal of this analysis is a better understanding of the issues involved in establishing the amount of change in pain that must be reported by subjects, participating in clinical trials and using standard pain scales, to indicate a clinically important difference. Design: A review of the literature and a discussion of relevant concepts are presented. The focus is on outcome measures of pain commonly used in the studies described, including pain intensity, pain relief, global assessment of the medication effect, and requirement for an extra dose of rescue medication to treat a pain episode. The standard analysis statistics used to summarize the data an the central tendency of the groups being compared (i.e., mean, median, or mode), and the proportion of subjects that achieve one or more specific levels of benefit. Results: The analysis of the proportion of responders in the groups being compared allows for a more easily understandable clinical importance of the results. Conclusions: An analysis of the proportion of responders is a clinically relevant analysis for many pain clinical trials and should be presented for one or more levels of response as appropriate. This will allow the readers to more easily interpret the results and apply them to clinical practice.
引用
收藏
页码:S106 / S112
页数:7
相关论文
共 50 条
  • [1] Defining the clinically important difference in pain outcome measures
    Farrar, JT
    Portenoy, RK
    Berlin, JA
    Kinman, JL
    Strom, BL
    PAIN, 2000, 88 (03) : 287 - 294
  • [2] Clinically important changes in acute pain outcome measures: A validation study
    Farrar, JT
    Berlin, JA
    Strom, BL
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (05) : 406 - 411
  • [3] Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations
    McGrath, Patrick J.
    Walco, Gary A.
    Turk, Dennis C.
    Dworkin, Robert H.
    Brown, Mark T.
    Davidson, Karina
    Eccleston, Christopher
    Finley, G. Allen
    Goldschneider, Kenneth
    Haverkos, Lynne
    Hertz, Sharon H.
    Ljungman, Gustaf
    Palermo, Tonya
    Rappaport, Bob A.
    Rhodes, Thomas
    Schechter, Neil
    Scott, Jane
    Sethna, Navil
    Svensson, Ola K.
    Stinson, Jennifer
    von Baeyer, Carl L.
    Walker, Lynn
    Weisman, Steven
    White, Richard E.
    Zajicek, Anne
    Zeltzer, Lonnie
    JOURNAL OF PAIN, 2008, 9 (09) : 771 - 783
  • [4] Clinical outcome measures for progressive MS trials
    Ontaneda, Daniel
    Cohen, Jeffrey A.
    Amato, Maria Pia
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1627 - 1635
  • [5] Outcome Measures for Clinical Trials in Down Syndrome
    Esbensen, Anna J.
    Hooper, Stephen R.
    Fidler, Deborah
    Hartley, Sigan L.
    Edgin, Jamie
    d'Ardhuy, Xavier Liogier
    Capone, George
    Conners, Frances A.
    Mervis, Carolyn B.
    Abbeduto, Leonard
    Rafii, Michael
    Krinsky-McHale, Sharon J.
    Urv, Tiina
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2017, 122 (03): : 247 - 281
  • [6] Outcome measures for early phase clinical trials
    Gordon, Paul H.
    Cheng, Bin
    Montes, Jacqueline
    Doorish, Carolyn
    Albert, Steven M.
    Mitsumoto, Hiroshi
    AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (05): : 270 - 273
  • [7] Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma
    De Moraes, C. Gustavo
    Liebmann, Jeffrey M.
    Levin, Leonard A.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2017, 56 : 107 - 147
  • [8] Digital outcome measures in pulmonary clinical trials
    Farrand, Erica
    Swigris, Jeffrey J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (04) : 322 - 327
  • [9] Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials
    Raghu, Ganesh
    Collard, Harold R.
    Anstrom, Kevin J.
    Flaherty, Kevin R.
    Flemings, Thomas R.
    King, Talmadge E., Jr.
    Martinee, Fernando J.
    Brown, Kevin K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (10) : 1044 - 1048
  • [10] Clinical Trials and Outcome Measures in Adults With Hearing Loss
    Munro, Kevin J.
    Whitmer, William M.
    Heinrich, Antje
    FRONTIERS IN PSYCHOLOGY, 2021, 12